Harsh G R, Nishimura R N, Dwyer B E, Levin V A
Exp Neurol. 1986 Oct;94(1):21-8. doi: 10.1016/0014-4886(86)90268-2.
These studies used L-[14C]fucose to identify 9L brain tumors in rats. Ten days after intracranial implantation of 9L tumor cells, labeled L-fucose was injected intravenously. Autoradiography demonstrated high levels of radioactive L-fucose in the resultant 9L tumors but very little L-fucose in normal brain tissue. In vitro studies comparing uptake of labeled fucose into 9L cells, normal rat fibroblasts and transformed rat fibroblasts, rat astrocytes, and human brain tissue suggest that fucose is not preferentially transported into the 9L cells. These data imply that a permissive blood-brain barrier rather than differences in fucose metabolism underlie 9L tumor labeling.
这些研究使用L-[14C]岩藻糖来识别大鼠体内的9L脑肿瘤。在颅内植入9L肿瘤细胞10天后,静脉注射标记的L-岩藻糖。放射自显影显示,在生成的9L肿瘤中有高水平的放射性L-岩藻糖,但在正常脑组织中L-岩藻糖含量极少。体外研究比较了标记岩藻糖在9L细胞、正常大鼠成纤维细胞和转化大鼠成纤维细胞、大鼠星形胶质细胞以及人类脑组织中的摄取情况,结果表明岩藻糖并非优先转运至9L细胞中。这些数据表明,9L肿瘤标记的基础是血脑屏障通透性增加,而非岩藻糖代谢存在差异。